AN ADOLESCENT CASE OF RETROPERITONEAL PURE CHORIOCARCINOMA - SUCCESSFUL TREATMENT WITH MCNU-CONTAINING HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER MULTIPLE BRAIN METASTASES
Y. Nagatoshi et al., AN ADOLESCENT CASE OF RETROPERITONEAL PURE CHORIOCARCINOMA - SUCCESSFUL TREATMENT WITH MCNU-CONTAINING HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AFTER MULTIPLE BRAIN METASTASES, Pediatric hematology and oncology, 13(2), 1996, pp. 167-171
Choriocarcinoma is a rare disease in pediatric neoplasms. The prognosi
s of the disease is extremely poor once when patients relapse or becom
e refractory bo cisplatin (CDDP). A 17-year-old male who had retroperi
toneal pure choriocarcinoma of advanced stage was treated with CDDP-ba
sed intensive chemotherapy. In spire of the initial goad response to C
DDP-based intensive chemotherapy, the tumor metastasized to multiple a
reas of the brain during chemotherapy. Since the brain in this case wa
s thought to be a sanctuary, after radiotherapy to the whole cranium,
the patient was treated with high-dose chemotherapy consisting of etop
oside, carboplatin, and ranimustine (MCNU), which can penetrate the bl
ood-brain barrier, followed by autologous bone marrow transplantation
(ABMT). Twenty-four months after ABMT, the patient had no sign of dise
ase recurrence. MCNU-containing high-dose chemotherapy with ABMT appea
rs to be quite effective in cases that present with relapsing multiple
brain metastases during CDDP-based chemotherapy.